CMSC News: In Memoriam - Dr. William Sheremata
Monday, April 17, 2017
Posted by: Elizabeth Porco
William A. Sheremata, M.D., emeritus professor of neurology at the University of Miami Miller School of Medicine, passed away on March 29 – but not before learning that the Food and Drug Administration (FDA) approved a ground-breaking drug for multiple sclerosis. “Dr. Sheremata wass a distinguished educator, clinician and researcher,” said Laurence B. Gardner, M.D., Interim Dean of the Miller School. Internationally renowned for his research on multiple sclerosis and other neurological disorders, Dr. William Sheremata spent more than 40 years on the Miller School faculty. He will be missed by his family, colleagues, and his patients.
The industry news information and articles are for informational purposes only, and are not intended to represent any trends, partnerships, commitments, or research of the Consortium of MS Centers or any of it's members in any way whatsoever, nor should any party be libel in any way to the reader or to any other person, firm or corporation reading this industry news section. Although the CMSC site includes links providing direct access to other Internet sites, CMSC takes no responsibility for the content or information contained on those other sites, and does not exert any editorial or other control over those other sites. CMSC is providing information and services on the Internet as a benefit and service in furtherance of CMSC's nonprofit and tax-exempt status. CMSC makes no representations about the suitability of this information and these services for any purpose.